[go: up one dir, main page]

FR2796281B1 - Vaccin inactive contre la calicivirose feline - Google Patents

Vaccin inactive contre la calicivirose feline

Info

Publication number
FR2796281B1
FR2796281B1 FR9909420A FR9909420A FR2796281B1 FR 2796281 B1 FR2796281 B1 FR 2796281B1 FR 9909420 A FR9909420 A FR 9909420A FR 9909420 A FR9909420 A FR 9909420A FR 2796281 B1 FR2796281 B1 FR 2796281B1
Authority
FR
France
Prior art keywords
calicivirose
vaccine against
against feline
inactive vaccine
inactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9909420A
Other languages
English (en)
Other versions
FR2796281A1 (fr
Inventor
Herve Poulet
Sylvain Gabriel Goutebroze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial SAS
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial SAS, Merial Inc filed Critical Merial SAS
Priority to FR9909420A priority Critical patent/FR2796281B1/fr
Priority to FR0001759A priority patent/FR2796282B1/fr
Priority to DK00953242T priority patent/DK1194450T3/da
Priority to DE60015127T priority patent/DE60015127T2/de
Priority to EP00953242A priority patent/EP1194450B1/fr
Priority to KR1020027000615A priority patent/KR100859824B1/ko
Priority to PCT/FR2000/002050 priority patent/WO2001005835A1/fr
Priority to ES00953242T priority patent/ES2231233T3/es
Priority to CA2378802A priority patent/CA2378802C/fr
Priority to KR1020087001920A priority patent/KR20080012405A/ko
Priority to PL352461A priority patent/PL205298B1/pl
Priority to HU0202389A priority patent/HU228430B1/hu
Priority to JP2001511492A priority patent/JP4841775B2/ja
Priority to AU65764/00A priority patent/AU6576400A/en
Priority to MXPA02000536A priority patent/MXPA02000536A/es
Priority to AT00953242T priority patent/ATE280182T1/de
Priority to PT00953242T priority patent/PT1194450E/pt
Priority to BRPI0012500-8A priority patent/BR0012500B1/pt
Priority to KR1020097000095A priority patent/KR100934687B1/ko
Priority to US09/616,781 priority patent/US6534066B1/en
Priority to ARP000103658A priority patent/AR024770A1/es
Publication of FR2796281A1 publication Critical patent/FR2796281A1/fr
Application granted granted Critical
Publication of FR2796281B1 publication Critical patent/FR2796281B1/fr
Priority to ZA200201232A priority patent/ZA200201232B/en
Priority to US10/368,861 priority patent/US7029682B2/en
Priority to US11/038,682 priority patent/US20100041023A9/en
Priority to US11/040,670 priority patent/US7850978B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C07K16/106—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation
    • C12N2770/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9909420A 1999-07-16 1999-07-16 Vaccin inactive contre la calicivirose feline Expired - Lifetime FR2796281B1 (fr)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FR9909420A FR2796281B1 (fr) 1999-07-16 1999-07-16 Vaccin inactive contre la calicivirose feline
FR0001759A FR2796282B1 (fr) 1999-07-16 2000-02-11 Vaccin inactive contre la calicivirose feline
AT00953242T ATE280182T1 (de) 1999-07-16 2000-07-13 Inaktivierter impfstoff gegen katzen calicivirus
EP00953242A EP1194450B1 (fr) 1999-07-16 2000-07-13 Vaccin inactive contre la calicivirose feline
KR1020027000615A KR100859824B1 (ko) 1999-07-16 2000-07-13 고양이 칼리시바이러스 질병에 대한 불활성화 백신
PCT/FR2000/002050 WO2001005835A1 (fr) 1999-07-16 2000-07-13 Vaccin inactive contre la calicivirose feline
ES00953242T ES2231233T3 (es) 1999-07-16 2000-07-13 Vacuna inactivada contra la enfermedad de la calicivirosis felina.
CA2378802A CA2378802C (fr) 1999-07-16 2000-07-13 Vaccin inactive contre la calicivirose feline
KR1020087001920A KR20080012405A (ko) 1999-07-16 2000-07-13 고양이 칼리시바이러스 질병에 대한 불활성화 백신
PL352461A PL205298B1 (pl) 1999-07-16 2000-07-13 Immunogenny preparat lub szczepionka przeciwko kalciwirusom kotów, hybrydoma oraz przeciwciało monoklonalne
HU0202389A HU228430B1 (en) 1999-07-16 2000-07-13 Inactivated vaccine against feline calicivirus disease
JP2001511492A JP4841775B2 (ja) 1999-07-16 2000-07-13 ネコカリチウイルス病に対する不活性ワクチン
DK00953242T DK1194450T3 (da) 1999-07-16 2000-07-13 Inaktiveret vaccine imod felin calicivirose
MXPA02000536A MXPA02000536A (es) 1999-07-16 2000-07-13 Vacuna inactivada contra la enfermedad provocada por el calicivirus de los felinos.
DE60015127T DE60015127T2 (de) 1999-07-16 2000-07-13 Inaktivierter impfstoff gegen katzen calicivirus
PT00953242T PT1194450E (pt) 1999-07-16 2000-07-13 Vacina inactivada contra a calicivirose felina
BRPI0012500-8A BR0012500B1 (pt) 1999-07-16 2000-07-13 vacina inativa contra a calicivirose felina.
KR1020097000095A KR100934687B1 (ko) 1999-07-16 2000-07-13 고양이 칼리시바이러스 질병에 대한 불활성화 백신
AU65764/00A AU6576400A (en) 1999-07-16 2000-07-13 Inactivated vaccine against feline calicivirus disease
US09/616,781 US6534066B1 (en) 1999-07-16 2000-07-14 Inactivated vaccine against feline calicivirosis
ARP000103658A AR024770A1 (es) 1999-07-16 2000-07-17 Vacunas inactivadas efectivas contra la calicivirosis felina
ZA200201232A ZA200201232B (en) 1999-07-16 2002-02-13 Inactivated vaccine against feline calicivirus disease.
US10/368,861 US7029682B2 (en) 1999-07-16 2003-02-18 Inactivated vaccine against feline calicivirosis
US11/038,682 US20100041023A9 (en) 1999-07-16 2005-01-19 Inactivated FCV vaccines
US11/040,670 US7850978B2 (en) 1999-07-16 2005-01-21 Vaccine against feline calicivirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9909420A FR2796281B1 (fr) 1999-07-16 1999-07-16 Vaccin inactive contre la calicivirose feline

Publications (2)

Publication Number Publication Date
FR2796281A1 FR2796281A1 (fr) 2001-01-19
FR2796281B1 true FR2796281B1 (fr) 2001-10-26

Family

ID=9548322

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9909420A Expired - Lifetime FR2796281B1 (fr) 1999-07-16 1999-07-16 Vaccin inactive contre la calicivirose feline

Country Status (2)

Country Link
FR (1) FR2796281B1 (fr)
ZA (1) ZA200201232B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2184567C1 (ru) * 2001-05-16 2002-07-10 Федеральное государственное учреждение Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов - центр качества ветеринарных препаратов и кормов Штамм feline calicivirus, используемый для контроля иммуногенной активности вакцин, изготовления специфических лечебно-профилактических и диагностических биопрепаратов

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231863B1 (en) * 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2184567C1 (ru) * 2001-05-16 2002-07-10 Федеральное государственное учреждение Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов - центр качества ветеринарных препаратов и кормов Штамм feline calicivirus, используемый для контроля иммуногенной активности вакцин, изготовления специфических лечебно-профилактических и диагностических биопрепаратов

Also Published As

Publication number Publication date
FR2796281A1 (fr) 2001-01-19
ZA200201232B (en) 2002-08-30

Similar Documents

Publication Publication Date Title
NO20014323L (no) Vaksine
NO20021400D0 (no) Terapeutiske konazolinderivater
DK1637127T3 (da) Terapeutisk mikroskum
ATE263748T1 (de) Admantan-derivate
ATE540013T1 (de) Naphthalinderivate
ATE293104T1 (de) Thiazolylamid-derivate
DZ3219A1 (fr) Vaccin
DE60002650D1 (de) Öladjuvierter Impfstoff
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
NO20015670L (no) Forbedrede farmasöytiske formuleringer
ATE257148T1 (de) Propargyletherderivate
NO20022606L (no) Farmasöytiske kombinasjoner
DK1154988T3 (da) Mevinolinderivater
NO20014926D0 (no) Farmasöytiske forbindelser
ATE374747T1 (de) Monofluoralkylderivate
DE60006703D1 (de) 4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE293592T1 (de) Resorcinderivate
ID30397A (id) Larutan oral prukaloprida
DK1189886T3 (da) Ethansulfonyl-piperidinderivater
IS6163A (is) Lyfjakomplex
DK1178984T3 (da) 1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
NO20015380D0 (no) Tio-oksindolderivater
EE200300045A (et) Kristalne ravimaine
DK1194450T3 (da) Inaktiveret vaccine imod felin calicivirose

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20